CLONING HEMATOPOIETIC GENES BY MRNA DIFFERENTIAL DISPLAY

Information

  • Research Project
  • 2230911
  • ApplicationId
    2230911
  • Core Project Number
    R43HL053132
  • Full Project Number
    1R43HL053132-01
  • Serial Number
    53132
  • FOA Number
    RFA-PH-S9-2S
  • Sub Project Id
  • Project Start Date
    9/1/1994 - 30 years ago
  • Project End Date
    3/31/1995 - 29 years ago
  • Program Officer Name
  • Budget Start Date
    9/1/1994 - 30 years ago
  • Budget End Date
    3/31/1995 - 29 years ago
  • Fiscal Year
    1994
  • Support Year
    1
  • Suffix
  • Award Notice Date
    8/23/1994 - 30 years ago
Organizations

CLONING HEMATOPOIETIC GENES BY MRNA DIFFERENTIAL DISPLAY

Advances in the use of hematopoietic stem cells for transplantation and gene therapy have increased the urgency for a better knowledge of the molecular control of their development and proliferation. An understanding of the molecular processes involved in the earliest stages of stem cell development, currently poorly understood, would provide very useful guide to the selection, expansion and ex-vivo manipulation of stem cells. Our long-term objective is to identify, clone and investigate these genes. An in vitro assay is now available which allow totipotent murine embryonic stem (ES) cells to develop into hematopoietic cells. This transition must involve the activatiOn of the earliest genetic program for initiating hematopoiesis. By comparison with mRNA species from ES cells that are not differentiating into hematopoietic cells, these mRNA may be detected and cloned. A new PCR-based technique has made it possible to obtain "differential display" of mRNA species between two population of cells. We will combine these two technological advances to identify and clone cDNAs of stem cell related genes which could include receptors, transcriptional factors, adhesion molecules and structural protein unique and specific to hematopoietic cells. Together they should have a wide range of potential application technologically and commercially.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R43
  • Administering IC
    HL
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    839
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    HEM
  • Study Section Name
    Hematology Subcommittee 2
  • Organization Name
    CYTOMED, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    CAMBRIDGE
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    02139
  • Organization District
    UNITED STATES